Zhenguo Cheng Selected Research

DNA-Binding Proteins (DNA Binding Protein)

5/2022

The two-faced role of ATF2 on cisplatin response in gastric cancer depends on p53 context.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenguo Cheng Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 12/2014
7	Stomach Neoplasms (Stomach Cancer) 01/2023 - 07/2015
5	Neoplasm Metastasis (Metastasis) 11/2023 - 09/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 11/2017
2	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 01/2023
2	Esophageal Squamous Cell Carcinoma 01/2022 - 11/2020
2	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2013
1	Cytokine Release Syndrome 11/2023
1	Hypoxia (Hypoxemia) 09/2023
1	Dental Pulp Calcification (Denticle) 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Trigeminal Neuralgia (Tic Douloureux) 07/2022
1	Pituitary Neoplasms (Pituitary Adenoma) 12/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Lymphatic Metastasis 06/2017
1	Carcinogenesis 12/2014

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2017
4	Chimeric Antigen ReceptorsIBA 04/2024 - 06/2022
4	Interleukin-12 (IL 12)IBA 09/2023 - 11/2017
3	p21-Activated KinasesIBA 01/2019 - 10/2013
3	MicroRNAs (MicroRNA)IBA 06/2018 - 12/2014
2	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 11/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2018
1	Oxygen (Dioxygen)IBA 09/2023
1	pyranose oxidaseIBA 01/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	AntigensIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	Fibronectins (Fibronectin)IBA 01/2023
1	Viral AntigensIBA 06/2022
1	DNA-Binding Proteins (DNA Binding Protein)IBA 05/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022
1	EnzymesIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	brusatolIBA 01/2022
1	Amino Acids FDA Link 01/2022
1	ResveratrolIBA 01/2022
1	licochalcone AIBA 01/2022
1	interleukin-21 (interleukin 21)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Caveolin 1IBA 12/2020
1	Factor V (Coagulation Factor V)IBA 12/2020
1	Vaccine AdjuvantsIBA 01/2020
1	VaccinesIBA 01/2020
1	Estrogen Receptor alphaIBA 01/2019
1	OSM-LIF ReceptorsIBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 10/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2017
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 07/2015
1	Carbon DioxideIBA 07/2015
1	Carbonic Anhydrase IXIBA 07/2015
1	Cyclin-Dependent Kinase Inhibitor p57IBA 10/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2013
1	Small Interfering RNA (siRNA)IBA 10/2013
1	UbiquitinIBA 10/2013

Therapy/Procedure

9	Therapeutics 04/2024 - 12/2014
4	Immunotherapy 01/2023 - 11/2017
1	Oncolytic Virotherapy 11/2023
1	Intravenous Injections 11/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 09/2023
1	Intravenous Administration 01/2023
1	Rhizotomy 07/2022
1	Drug Therapy (Chemotherapy) 05/2022
1	Radiotherapy 01/2022